跳转至内容

Dear Customer:

The current international situation is complex and volatile, and uncertain tariff policies may potentially impact our product prices. Given these uncertainties, we value your understanding regarding order-related matters.

If you decide to place an order during this period, we reserve the right to adjust the price based on the evolving situation. We understand that market changes may cause inconvenience. We will negotiate with you if there’s a significant price fluctuation due to tariff policy changes before the order’s actual delivery, and in such cases we may adjust or cancel the order as necessary.

For important updates on recent policy changes, please click here for more details.

Merck
CN
所有图片(1)

主要文件

SML0974

Sigma-Aldrich

(+/-)-JQ1

≥98% (HPLC)

别名:

N-(2′,5′-二甲氧基 [1,1′-联苯 ]-4-基)-3-氟-4-吡啶甲酰胺, (+/-)-SGCBD01, [(R,S)-4-(4-氯苯基)-2,3,9-三甲基-6H-1-硫杂-5,7,8,9a-四氮杂-环戊环[e]氮杂-6-基]-乙酸叔丁酯

登录查看公司和协议定价

选择尺寸

5 MG
CN¥2,526.62
25 MG
CN¥8,108.18

CN¥2,526.62


国内现货,预计发货时间April 23, 2025详情


获取大包装报价

选择尺寸

变更视图
5 MG
CN¥2,526.62
25 MG
CN¥8,108.18

About This Item

经验公式(希尔记法):
C23H25ClN4O2S
分子量:
456.99
MDL编号:
UNSPSC代码:
51111800
PubChem化学物质编号:
NACRES:
NA.77

CN¥2,526.62


国内现货,预计发货时间April 23, 2025详情


获取大包装报价

质量水平

方案

≥98% (HPLC)

表单

powder

药品控制

regulated under CDSA - not available from Sigma-Aldrich Canada

颜色

white to beige

溶解性

DMSO: 2 mg/mL, clear (warmed)

储存温度

2-8°C

SMILES字符串

CC1=NN=C2N1C3=C(C(C)=C(C)S3)C(C4=CC=C(Cl)C=C4)=NC2CC(OC(C)(C)C)=O

InChI

1S/C23H25ClN4O2S/c1-12-13(2)31-22-19(12)20(15-7-9-16(24)10-8-15)25-17(11-18(29)30-23(4,5)6)21-27-26-14(3)28(21)22/h7-10,17H,11H2,1-6H3

InChI key

DNVXATUJJDPFDM-UHFFFAOYSA-N

比较类似商品

查看完整比较结果

显示差异

1 of 4

此商品
SML0262SML1524SML1525
(+/-)-JQ1 ≥98% (HPLC)

SML0974

(+/-)-JQ1

GSK575594A ≥98% (HPLC)

SML0262

GSK575594A

(+)-JQ1 ≥98% (HPLC)

SML1524

(+)-JQ1

(-)-JQ1 ≥95% (HPLC)

SML1525

(-)-JQ1

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥95% (HPLC)

drug control

regulated under CDSA - not available from Sigma-Aldrich Canada

drug control

regulated under CDSA - not available from Sigma-Aldrich Canada

drug control

-

drug control

-

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

solubility

DMSO: 2 mg/mL, clear (warmed)

solubility

DMSO: ≥5 mg/mL

solubility

DMSO: 20 mg/mL, clear

solubility

DMSO: 20 mg/mL, clear

应用

通过分析其对脂肪形成的基因调控的影响,特别是对过氧化物酶体增殖物激活受体 (PPAR-g)、CCAAT/增强子结合蛋白(C/EBPa)以及STAT5A和B的影响,(±)-JQ1已被用来研究其对脂肪形成的影响。[1]JQ1已作为BRD4化学抑制剂用于药物结合试验,以研究CRBN在小鼠和人类中的底物募集功能。[2]

生化/生理作用

(+/-)-JQ1 是 Brd4 抑制剂。
(±)-JQ1 是 Brd4 抑制剂。已知 JQ1 抑制细胞增殖,因此,可用作编号癌症的治疗药物,包括多发性骨髓瘤和急性髓性白血病。[3]
人类 BET 家族包括 BRD2、BRD3、BRD4 和 BRDT,在基因转录调控中起作用。(+/-)-JQ1 ((+/-) SGCBD01) 是一种选择性 BET 溴结构域 (BRD) 抑制剂,可抑制 Brd4(含溴结构域 4)。Brd4 通过两个串联的溴结构域(BD1 和 BD2)与染色质形成复合物,这两个结构域与组蛋白中的乙酰化赖氨酸残基结合,Brd4 与乙酰化染色质结合被认为可调节延伸因子 b 和额外转录因子向特异性启动子区域的募集。已知睾丸核蛋白 (NUT) 基因可与 Brd4 形成融合,从而产生一种有效的致癌基因,导致罕见但高度致死的肿瘤,称为 NUT 中线癌 (NMC)。JQ1 抑制 Brd4 与 TNFα 的招募和结合和 E-选择素启动子元件,并在使用 GFP-Brd4 的 FRAP(光漂白后荧光恢复)分析中加速恢复时间。因此 JQ1/SGCBD01 是研究 Brd4 在转录起始中角色的有用工具。有关表征的完整详细信息,请访问 Structural Genomics Consortium (SGC) 网站上的 SGCBD01/JQ1 探针摘要

要了解表观遗传靶标的其他 SGC 化学探针,请访问 sigma.com/sgc

特点和优势

(+/-) JQ-1是一种表观遗传化学探针,是我们与Structural Genomics Consortium (SGC)合作研发的。想要了解更多信息并查看其他SGC表观遗传探针,请访问sigma.com/SGC
该化合物是基因调控研究的特色产品。 点击此处 ,发现更多特色基因调控产品。在 sigma.com/discover-bsm可了解更多关于其他研究领域的生物活性小分子。

目标描述

Brd4 inhibitor

其他说明

化学探针门户网站已对 JQ1 进行了专家评审和推荐。如需信息更多信息,请访问化学探针门户网站上的 JQ1 探针摘要
外消旋混合物

相关产品

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


  • 历史批次信息供参考:

    分析证书(COA)

    Lot/Batch Number

    没有发现合适的版本?

    如果您需要特殊版本,可通过批号或批次号查找具体证书。

    已有该产品?

    在文件库中查找您最近购买产品的文档。

    访问文档库

    Ying Liang et al.
    Nature communications, 13(1), 7329-7329 (2022-11-29)
    Technologies for gene activation are valuable tools for the study of gene functions and have a wide range of potential applications in bioengineering and medicine. In contrast to existing methods based on recruiting transcriptional modulators via DNA-binding proteins, we developed
    Yunlu Jia et al.
    Blood cancer journal, 11(2), 32-32 (2021-02-14)
    Multiple myeloma (MM) is an aggressive plasma cell neoplasm characterized by genomic heterogeneity. Superenhancers (SEs) are defined as large clusters of enhancers in close genomic proximity, which regulate genes for maintaining cellular identity and promote oncogenic transcription to which cancer
    Panagis Filippakopoulos et al.
    Nature, 468(7327), 1067-1073 (2010-09-28)
    Epigenetic proteins are intently pursued targets in ligand discovery. So far, successful efforts have been limited to chromatin modifying enzymes, or so-called epigenetic 'writers' and 'erasers'. Potent inhibitors of histone binding modules have not yet been described. Here we report
    Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon.
    Akuffo A A, et al.
    The Journal of Biological Chemistry (2018)
    Hiroki Michida et al.
    Cell reports, 31(9), 107724-107724 (2020-06-04)
    NF-κB is a transcription factor that activates super enhancers (SEs) and typical enhancers (TEs) and triggers threshold and graded gene expression, respectively. However, the mechanisms by which NF-κB selectively participates in these enhancers remain unclear. Here we show using mouse

    我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系客户支持